Key result
Isoproterenol unmasks a concealed anteroseptal accessory pathway, enabling successful ablation with zero 18-month recurrences.
Why the study?
Isoproterenol-dependent concealed right anteroseptal accessory pathways are rare and may not be identified or induced during baseline electrophysiological study.
Does intravenous isoproterenol provocation during electrophysiological study unmask concealed right anteroseptal accessory pathways to enable successful radiofrequency ablation in patients with uninducible narrow-complex tachycardia at baseline?
Case Report (n=1)
No
Does intravenous isoproterenol provocation during electrophysiological study unmask concealed right anteroseptal accessory pathways to enable successful radiofrequency ablation in patients with uninducible narrow-complex tachycardia at baseline?
This case highlights the crucial diagnostic utility of isoproterenol provocation during electrophysiological studies to unmask rare, catecholamine-dependent concealed right anteroseptal accessory pathways when baseline stimulation fails to induce narrow-complex tachycardia.
Answers are grounded in this paper and cite their sources.
Isoproterenol provocation may facilitate ablation of rare concealed pathways; leaves open generalizability and requires prospective validation.
A 34-year-old male with no history of chronic medical illness or regular medication use presented with recurrent palpitations, chest tightness, and presyncope over two weeks. A wearable smart device recorded brief runs of irregular narrow-complex tachycardia, which were initially misdiagnosed as paroxysmal atrial fibrillation. During baseline electrophysiological study (EPS), ventriculoatrial (VA) conduction exhibited Wenckebach periodicity; no accessory pathway (AP) was identified, and no supraventricular tachycardia (SVT) could be induced. Following intravenous isoproterenol (ISO) infusion, retrograde conduction improved, and narrow-complex tachycardia was successfully induced via programmed stimulation [S1S2 coupling intervals of 330/210 milliseconds (ms)] from the coronary sinus. Orthodromic atrioventricular reentrant tachycardia (AVRT) was confirmed. The concealed AP was localized to the right anteroseptal region (specifically, the 12–1 o'clock position on the tricuspid annulus) and was successfully ablated using radiofrequency energy. Post-ablation EPS demonstrated non-inducibility of tachycardia. The patient remained free of arrhythmia recurrence during 18 months of clinical follow-up. This case illustrates a rare isoproterenol-dependent concealed right anteroseptal AP and underscores the diagnostic utility of ISO provocation in patients with narrow-complex tachycardia when arrhythmia is not induced on standard EPS.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a case report in Orthodromic atrioventricular reentrant tachycardia (AVRT) via a concealed right anteroseptal accessory pathway (n=1). Isoproterenol provocation followed by radiofrequency catheter ablation was evaluated on Arrhythmia non-inducibility and freedom from clinical tachycardia recurrence at 18 months. Intravenous isoproterenol (1-/min) unmasked a concealed right anteroseptal accessory pathway, enabling 35 W radiofrequency ablation and 18 months of arrhythmia-free follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: